Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Neuropharmacology. 2023 Mar 6;230:109489. doi: 10.1016/j.neuropharm.2023.109489

Fig. 3.

Fig. 3.

The allosteric effect of the 5-HT2AR agonist DOI on the affinity of LY379268 displacing the mGluR2/3 antagonist [3H]LY341495 is increased in frontal cortex samples of schizophrenia subjects. This suggests that the functional crosstalk between 5-HT2AR and mGluR2 as a GPCR heterocomplex may be involved in the altered cortical processes in schizophrenia patients.